[July 29, 2016] |
|
Global RNA-Dependent RNA Polymerase (RdRP or RNA Replicase) Inhibitors Pipeline Insights Report 2016 - Research and Markets
Research and Markets has announced the addition of the "RNA-Dependent
RNA Polymerase (RdRP or RNA Replicase) Inhibitors -Pipeline Insights,
2016" report to their offering.
RNA-Dependent RNA Polymerase (RdRP or RNA Replicase) Inhibitors-Pipeline
Insights, 2016 provides in depth insights on the pipeline drugs and
their development activities around the RNA-Dependent RNA Polymerase
(RdRP or RNA Replicase) Inhibitors. The report covers the product
profiles in various stages of development including Discovery,
Pre-clinical, IND, Phase I, Phase II, Phase III and Preregistration.
Report covers the product clinical trials information and other
development activities including technology, licensing, collaborations,
acquisitions, fundings, patent and USFDA & EMA (News - Alert) designations details.
The report also provides detailed information on the discontinued and
dormant drugs that have gone inactive over the years for RNA-Dependent
RNA Polymerase (RdRP or RNA Replicase) Inhibitors.
The report also assesses the RNA-Dependent RNA Polymerase (RdRP or RNA
Replicase) Inhibitors therapeutics by Monotherapy, Combination products,
molecule type and Route of Administration.
<>
Scope
-
The report provides competitive pipeline landscape of RNA-Dependent
RNA Polymerase (RdRP or RNA Replicase) Inhibitors
-
The report provides pipeline products under drug profile section which
includes product description, MOA, licensors & collaborators,
development partner and chemical information
-
Coverage of the RNA-Dependent RNA Polymerase (RdRP or RNA Replicase)
Inhibitors pipeline on the basis of target, MOA, route of
administration, technology involved and molecule type
-
The report reviews key players involved in the therapeutics
development for RNA-Dependent RNA Polymerase (RdRP or RNA Replicase)
Inhibitors and also provide company profiling
-
The report also gives the information of dormant and discontinued
pipeline projects
-
Pipeline products coverage based on various stages of development
ranging from preregistration till discovery and undisclosed stages
-
Provides pipeline assessment by monotherapy and combination therapy
products, stage of development and molecule type
Key Topics Covered:
-
Overview
-
Pipeline Therapeutics
-
Therapeutics under Development by Companies
-
Filed and Phase III Products
-
Comparative Analysis
-
Phase II Products
-
Comparative Analysis
-
Phase I and IND Filed Products
-
Comparative Analysis
-
Discovery and Pre-Clinical Stage Products
-
Comparative Analysis
-
Drug Candidate Profiles
-
Therapeutics Assessment
-
Assessment by Monotherapy Products
-
Assessment by Combination Products
-
Assessment by Route of Administration
-
Assessment by Molecule Type
-
Discontinued Products
-
Dormant Products
-
Companies Involved in Therapeutics Development
For more information visit http://www.researchandmarkets.com/research/sl7tkl/rnadependent_rna
View source version on businesswire.com: http://www.businesswire.com/news/home/20160729005658/en/
[ Back To TMCnet.com's Homepage ]
|